Art

J-GLOBAL ID：202002276146761593   Reference number：20A2286843

Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19

COVID-19に対する分子病因,免疫病原性および新規治療戦略【JST・京大機械翻訳】

Author (4)： Chatterjee Swapan K. (Molecular Pharma Pvt., Ltd., Kolkata, India) ,  Saha Snigdha (Molecular Pharma Pvt., Ltd., Kolkata, India) ,  Munoz Maria Nilda M. (Cagayan State University, Tuguegarao City, Philippines) ,  Munoz Maria Nilda M. (De La Salle University, Manila, Philippines)
Material： Frontiers in Molecular Biosciences (Web)
Volume： 7  Page： 196  Publication year： 2020 
JST Material Number： U7081A  ISSN： 2296-889X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： The coronavirus disease 2019 (...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2286843&from=J-GLOBAL&jstjournalNo=U7081A") }}

Thesaurus term： interaction ,  viral infection ,  antibody ,  receptor ,  human(primates) ,  vaccine ,  *pathogenicity ,  lectin ,  cytokine ,  epithelial cell ,  interleukin 6 ,  *pathogenesis ,  inflammation mediator
Semi thesaurus term： コロナウイルス ,  急性肺損傷 , 【Automatic Indexing@JST】

Author keywords (7)： SARS-CoV-2 ,  COVID-19 ,  TMPRSS2 ,  cytokine storm ,  Mannose-binding lectin ,  innate immunity ,  immunomodulators

JST classification (1)： Physiology and pathogenicity of virus infection  (EG04042Y)

Reference (64)：

• Belouzard S., Chu V. C., Whittaker G. R. (2009). Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. U.S.A. 106 5871-5876. doi: 10.1073/pnas.0809524106
• Bourgonje A. R., Abdulle A. E., Timens W., Hillebrands J. L., Navis G. J., Gordijn S. J., et al (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. [Online ahead of print] doi: 10.1002/path.5471
• Catanzaro M., Fagiani F., Racchi M., Corsini E., Govoni S., Lanni C. (2020). Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target. Ther. 5:84. doi: 10.1038/s41392-020-0191-1
• Chan J. F., Yuan S., Kok K. H., To K. K., Chu H., Yang J., et al (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 514-523. doi: 10.1016/s0140-6736(20)30154-9
• Corman V. M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D. K., et al (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro. Surveill. 25:2000045. doi: 10.2807/1560-7917

Terms in the title (4)： 分子 ,  病因 ,  免疫病原性 ,  治療戦略